6DA4

JAK3 with Cyanamide CP10

Summary for 6DA4

Entry DOI	10.2210/pdb6da4/pdb
Descriptor	Tyrosine-protein kinase JAK3, (Z)-1-{2,2-difluoro-6-[5-(2-methoxyethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-2,3-dihydro-4H-1,4-benzoxazin-4-yl}methanimine (3 entities in total)
Functional Keywords	kinase, covalent, transferase-inhibitor complex, transferase/inhibitor
Biological source	Homo sapiens (Human)
Total number of polymer chains	1
Total formula weight	36917.01
Authors	Vajdos, F.F. (deposition date: 2018-05-01, release date: 2018-11-28, Last modification date: 2019-05-01)
Primary citation	Casimiro-Garcia, A.,Trujillo, J.I.,Vajdos, F.,Juba, B.,Banker, M.E.,Aulabaugh, A.,Balbo, P.,Bauman, J.,Chrencik, J.,Coe, J.W.,Czerwinski, R.,Dowty, M.,Knafels, J.D.,Kwon, S.,Leung, L.,Liang, S.,Robinson, R.P.,Telliez, J.B.,Unwalla, R.,Yang, X.,Thorarensen, A. Identification of Cyanamide-Based Janus Kinase 3 (JAK3) Covalent Inhibitors. J. Med. Chem., 61:10665-10699, 2018 Cited by PubMed: 30423248 DOI: 10.1021/acs.jmedchem.8b01308 PDB entries with the same primary citation
Experimental method	X-RAY DIFFRACTION (2.9 Å)

Structure validation